Elongin BC complex prevents degradation of von Hippel-Lindau tumor suppressor gene products.
about
Cullin-RING ubiquitin ligases: global regulation and activation cyclesState of the science: an update on renal cell carcinomaAtlas on substrate recognition subunits of CRL2 E3 ligasesDesign and analysis of a Petri net model of the Von Hippel-Lindau (VHL) tumor suppressor interaction networkInterferon-inducible Myc/STAT-interacting protein Nmi associates with IFP 35 into a high molecular mass complex and inhibits proteasome-mediated degradation of IFP 35The SOCS2 ubiquitin ligase complex regulates growth hormone receptor levelsThe SOCS box of suppressor of cytokine signaling-1 is important for inhibition of cytokine action in vivoEC5S ubiquitin complex is recruited by KSHV latent antigen LANA for degradation of the VHL and p53 tumor suppressors.Differences in regulation of tight junctions and cell morphology between VHL mutations from disease subtypes.Mammalian SWI/SNF--a subunit BAF250/ARID1 is an E3 ubiquitin ligase that targets histone H2B.The von Hippel-Lindau protein interacts with heteronuclear ribonucleoprotein a2 and regulates its expression.Agents that stabilize mutated von Hippel-Lindau (VHL) protein: results of a high-throughput screen to identify compounds that modulate VHL proteostasis.Mouse model for noninvasive imaging of HIF prolyl hydroxylase activity: assessment of an oral agent that stimulates erythropoietin productionDiverse effects of mutations in exon II of the von Hippel-Lindau (VHL) tumor suppressor gene on the interaction of pVHL with the cytosolic chaperonin and pVHL-dependent ubiquitin ligase activity.ASB2 is an Elongin BC-interacting protein that can assemble with Cullin 5 and Rbx1 to reconstitute an E3 ubiquitin ligase complex.VHL, the story of a tumour suppressor gene.The Type II Hsp40 Sis1 cooperates with Hsp70 and the E3 ligase Ubr1 to promote degradation of terminally misfolded cytosolic protein.Characterization of the role of COP9 signalosome in regulating cullin E3 ubiquitin ligase activityOncogenic aberrations of cullin-dependent ubiquitin ligases.E2-EPF UCP regulates stability and functions of missense mutant pVHL via ubiquitin mediated proteolysis.Structural Basis for Modulation of Quality Control Fate in a Marginally Stable Protein.WSB1 promotes tumor metastasis by inducing pVHL degradationAllosteric effects in the marginally stable von Hippel-Lindau tumor suppressor protein and allostery-based rescue mutant design.Nek1 phosphorylates Von Hippel-Lindau tumor suppressor to promote its proteasomal degradation and ciliary destabilization.Downregulation of integrins by von Hippel-Lindau (VHL) tumor suppressor protein is independent of VHL-directed hypoxia-inducible factor alpha degradation.Interactions between HIV-1 Vif and human ElonginB-ElonginC are important for CBF-β binding to Vif.BC-box protein domain-related mechanism for VHL protein degradation.SOCS-1 localizes to the microtubule organizing complex-associated 20S proteasome.USP9X destabilizes pVHL and promotes cell proliferation.Phosphorylation-dependent cleavage regulates von Hippel Lindau proteostasis and function.Regulation of RNA polymerase II-mediated transcriptional elongation: Implications in human disease.Control of BACE1 degradation and APP processing by ubiquitin carboxyl-terminal hydrolase L1.cDNA array analysis of cag pathogenicity island-associated Helicobacter pylori epithelial cell response genes.The Hsp70 and TRiC/CCT chaperone systems cooperate in vivo to assemble the von Hippel-Lindau tumor suppressor complex.VHL mutations linked to type 2C von Hippel-Lindau disease cause extensive structural perturbations in pVHL.Hypoxia-inducible factor linked to differential kidney cancer risk seen with type 2A and type 2B VHL mutations.E2-EPF UCP targets pVHL for degradation and associates with tumor growth and metastasis.Mechanisms of SOCS3 phosphorylation upon interleukin-6 stimulation. Contributions of Src- and receptor-tyrosine kinases.An integrated computational approach can classify VHL missense mutations according to risk of clear cell renal carcinoma.Homo-PROTACs: bivalent small-molecule dimerizers of the VHL E3 ubiquitin ligase to induce self-degradation.
P2860
Q21203558-2995B6C7-F04F-4349-96ED-E8B5CC711BF0Q24630685-A9639356-5A77-488D-9479-7C708C676A34Q26750863-BE7E15CD-4C1B-4C68-B309-04D6477C0A5CQ27333673-A983D451-076B-4FFD-AE1A-8DF88EFDC043Q28144232-E9B594F6-94BB-4C55-8114-15D2D5255C53Q28477287-BD49F8D0-8F82-437D-8824-5410C7F8CF2DQ28588059-25479F8B-B076-4280-9CEF-C3AACAEC2EDEQ33261811-C222CCE3-5A82-4953-9F71-3383A50E7F6FQ33481999-83DB2285-C26A-4623-8446-EBC4D9115B2AQ33725449-DEF8BAC7-FD29-4F04-82AA-858CBED2C609Q34087732-C2C08708-8AA2-40A5-95B2-23D6C74F9DE8Q34167307-95E625B4-4B17-4C43-B880-9879850F4018Q34248310-2CB06432-9C51-4C34-A222-F31FFBF17262Q34323668-D6F9BBBC-5673-41C3-9EFE-7EC8ABB420ACQ34375157-9FE00CF1-C115-4ACA-9F97-8D2A8CEF0709Q34455226-A3955EC5-D3A1-4FFF-8A52-63F60725A819Q34558213-4AB0ED00-6414-4A02-8B4E-79DDB1235B69Q35612223-70F770C9-6D14-40D3-AC20-B60068F47330Q35691547-C51622F6-A731-49AA-A77D-807A74678517Q35821979-FCA3A26A-EBE0-4718-A70C-CCD9A2A80C5DQ35875159-5A65BF71-A250-4E38-B1D0-46323E762508Q36286769-57A7B3E4-57B7-4373-8498-A01CCCD0AF49Q36458965-6603B954-C2FE-453F-8BCA-25738B865206Q36604618-832404F7-FF2D-4F4D-9A47-2D5E31703ED8Q37001497-44D818F5-0636-4488-A57C-0DA14AC56655Q37153444-8DFC9F3B-6637-402C-B6A3-4115954B56D7Q37318235-E9212AC8-C233-425B-A80A-A8A5D1EE4439Q37527082-C575BDA3-02F4-452D-B40E-0C9395F86A86Q37645058-50E8C7E3-4559-46F8-AAD9-C2FE97E1BCD8Q38786652-776331BA-D125-4282-8675-A20BBE895027Q38912988-E627B1B7-F971-4E51-9170-213BFADE9B90Q39418939-87CA1930-9A1E-48C6-AEF0-482C96903CE9Q39529567-669F4A12-85A0-49AC-A465-AC30B984D194Q39745880-25FF274C-FB23-40B8-8E7E-257E13B53D05Q39882063-2FF88585-BE33-49D3-ADAA-C99D975D3793Q40127751-4C7F394E-779C-4614-AE1E-8F4CE135B1F8Q40259335-9231330C-38FE-44A5-B21D-A9C526A1B3B4Q40401298-B1B3A488-9B1F-48BD-BD4A-402B4F01491DQ41882621-F17CCBAD-0E83-463F-A2ED-1A41530A6706Q42217007-E68C8B6F-D708-474C-9EEB-F3BDA874309A
P2860
Elongin BC complex prevents degradation of von Hippel-Lindau tumor suppressor gene products.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2000
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Elongin BC complex prevents de ...... umor suppressor gene products.
@en
Elongin BC complex prevents de ...... umor suppressor gene products.
@nl
type
label
Elongin BC complex prevents de ...... umor suppressor gene products.
@en
Elongin BC complex prevents de ...... umor suppressor gene products.
@nl
prefLabel
Elongin BC complex prevents de ...... umor suppressor gene products.
@en
Elongin BC complex prevents de ...... umor suppressor gene products.
@nl
P2093
P2860
P356
P1476
Elongin BC complex prevents de ...... umor suppressor gene products.
@en
P2093
A R Schoenfeld
E J Davidowitz
P2860
P304
P356
10.1073/PNAS.97.15.8507
P407
P577
2000-07-01T00:00:00Z